Norinchukin Bank’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.47M Buy
81,861
+1,799
+2% +$161K 0.08% 127
2026
Q1
$5.75M Buy
80,062
+319
+0.4% +$24.6K 0.07% 159
2025
Q4
$6.33M Buy
79,743
+5,461
+7% +$431K 0.07% 145
2025
Q3
$5.6M Buy
74,282
+403
+0.5% +$27.6K 0.08% 144
2025
Q2
$5.1M Buy
73,879
+8,211
+13% +$538K 0.08% 159
2025
Q1
$4.45M Buy
65,668
+8,822
+16% +$528K 0.08% 153
2024
Q4
$2.55M Buy
56,846
+4,905
+9% +$275K 0.05% 201
2024
Q3
$3.27M Buy
51,941
+7,445
+17% +$434K 0.08% 151
2024
Q2
$2.63M Buy
44,496
+375
+0.8% +$23.5K 0.08% 155
2024
Q1
$3.52M Sell
44,121
-1,460
-3% -$112K 0.11% 129
2023
Q4
$3.6M Sell
45,581
-5,156
-10% -$367K 0.08% 119
2023
Q3
$3.54M Sell
50,737
-63,782
-56% -$4.52M 0.08% 126
2023
Q2
$7.92M Buy
114,519
+29,204
+34% +$2.08M 0.13% 116
2023
Q1
$6.34M Buy
85,315
+1,166
+1% +$97.8K 0.12% 111
2022
Q4
$7.84M Sell
84,149
-21,536
-20% -$2.08M 0.17% 88
2022
Q3
$10.1M Buy
105,685
+12,742
+14% +$1.26M 0.21% 73
2022
Q2
$8.61M Sell
92,943
-29,498
-24% -$2.88M 0.17% 84
2022
Q1
$12.4M Buy
122,441
+8,950
+8% +$940K 0.17% 94
2021
Q4
$11.7M Sell
113,491
-704
-0.6% -$65.1K 0.15% 98
2021
Q3
$9.69M Buy
114,195
+5,257
+5% +$440K 0.13% 108
2021
Q2
$9.09M Sell
108,938
-138
-0.1% -$11.3K 0.13% 100
2021
Q1
$8.21M Buy
109,076
+1,951
+2% +$142K 0.11% 100
2020
Q4
$7.32M Sell
107,125
-3,863
-3% -$251K 0.1% 101
2020
Q3
$6.48M Buy
110,988
+687
+0.6% +$42.7K 0.1% 101
2020
Q2
$7.17M Sell
110,301
-618
-0.6% -$38.9K 0.12% 91
2020
Q1
$6.58M Sell
110,919
-101,050
-48% -$6.75M 0.13% 90
2019
Q4
$15.7M Sell
211,969
-15,498
-7% -$1.09M 0.21% 82
2019
Q3
$14.3M Buy
227,467
+5,279
+2% +$313K 0.2% 84
2019
Q2
$12.1M Sell
222,188
-91,092
-29% -$4.91M 0.19% 81
2019
Q1
$16.9M Buy
313,280
+9,755
+3% +$602K 0.22% 88
2018
Q4
$19.9M Buy
303,525
+120,004
+65% +$8.96M 0.28% 65
2018
Q3
$14.4M Buy
183,521
+16,876
+10% +$1.21M 0.2% 92
2018
Q2
$10.7M Buy
166,645
+22,134
+15% +$1.46M 0.16% 95
2018
Q1
$8.99M Buy
144,511
+12,164
+9% +$873K 0.15% 98
2017
Q4
$9.6M Sell
132,347
-17,933
-12% -$1.3M 0.17% 89
2017
Q3
$12.2M Buy
150,280
+27,166
+22% +$2.15M 0.24% 74
2017
Q2
$9.91M Buy
123,114
+3,925
+3% +$310K 0.2% 78
2017
Q1
$9.36M Buy
119,189
+360
+0.3% +$28.7K 0.2% 79
2016
Q4
$9.38M Buy
118,829
+7,929
+7% +$642K 0.22% 69
2016
Q3
$9.87M Buy
110,900
+198
+0.2% +$18.7K 0.24% 64
2016
Q2
$10.6M Sell
110,702
-1,028
-0.9% -$102K 0.26% 65
2016
Q1
$11.6M Sell
111,730
-10,180
-8% -$990K 0.28% 57
2015
Q4
$11.9M Sell
121,910
-22,158
-15% -$2.17M 0.3% 52
2015
Q3
$13.9M Buy
144,068
+23,594
+20% +$2.48M 0.36% 40
2015
Q2
$12.6M Sell
120,474
-15,970
-12% -$1.63M 0.32% 45
2015
Q1
$14.1M Sell
136,444
-1,556
-1% -$157K 0.34% 43
2014
Q4
$13.3M Buy
138,000
+29,724
+27% +$2.62M 0.32% 43
2014
Q3
$8.62M Buy
108,276
+5,097
+5% +$402K 0.25% 52
2014
Q2
$7.78M Sell
103,179
-13,764
-12% -$1.04M 0.23% 52
2014
Q1
$8.75M Buy
116,943
+3,575
+3% +$253K 0.25% 52
2013
Q4
$8.11M Sell
113,368
-4,119
-4% -$265K 0.22% 54
2013
Q3
$6.67M Buy
117,487
+4,233
+4% +$252K 0.19% 57
2013
Q2
$6.48M Buy
+113,254
New +$6.56M 0.2% 54

Other funds holding CVS

Norinchukin Bank's CVS Position: Q2 2026 in Review

Norinchukin Bank increased its CVS Health (CVS) stake by 2.2% in Q2 2026, buying an estimated $161K and bringing the position to 81,861 shares worth $8.47M. The position accounts for 0.08% of the portfolio, ranked #127.

Norinchukin Bank first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.9M in Q4 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Norinchukin Bank held 81,861 shares of CVS Health worth $8.47M as of Q2 2026.
  • Norinchukin Bank bought 1,799 CVS Health shares in Q2 2026, an estimated $161K.
  • CVS Health made up 0.08% of Norinchukin Bank's portfolio in Q2 2026, its #127 holding.
  • Norinchukin Bank first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Norinchukin Bank's CVS Health position peaked at $19.9M in Q4 2018.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.